Ignite Creation Date:
2025-12-25 @ 2:13 AM
Ignite Modification Date:
2025-12-27 @ 12:03 PM
Study NCT ID:
NCT05335460
Status:
UNKNOWN
Last Update Posted:
2022-04-19
First Post:
2022-04-13
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
To Determine the Efficacy and Safety of Envafolimab Combined With XELOX for Locally Advanced Colon Cancer
Sponsor:
Fujian Cancer Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-05
Start Date Type:
ESTIMATED
Primary Completion Date:
2023-05
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-05
Completion Date Type:
ESTIMATED
First Submit Date:
2022-04-13
First Submit QC Date:
None
Study First Post Date:
2022-04-19
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-04-13
Last Update Post Date:
2022-04-19
Last Update Post Date Type:
ACTUAL